Glicoscienza

Sialyl-dimeric Lex-nona-APD-HSA is a monosaccharide that belongs to the group of complex carbohydrates. It is a custom synthesis product, which has been synthesized by the methylation and glycosylation of a high purity oligosaccharide. The structural formula for this product is C14H30FNO6S2. This product is highly purified and has been fluorinated at one hydroxyl group. Sialyl-dimeric Lex-nona-APD-HSA has CAS No. 569078-29-4 and molecular weight of 432.5 g/mol.br>
br>
This product can be used as a synthetic sugar in various applications such as food, pharmaceuticals, cosmetics, and agrochemicals industries.br>
br>
The following are some properties of this compound:
1) Nonvolatile solids content: 98%

D-Xylose-BSA is an anaesthetic agent that is used to treat depression and postoperative pain. It is a natural compound that has been found in the blood cells of humans and animals. D-Xylose-BSA interacts with endogenous receptors for biotinylated D-xylose on granulocytes, which leads to activation of these cells and consequent release of inflammatory mediators. The ability of D-xylose-BSA to bind to microbial surfaces may be due to its chemical structure, which consists of a glycosilated hydrophilic part and a lipid part. D-Xylose-BSA also binds to polymorphonuclear leukocytes, postoperative erythrocytes, and replanted skin grafts.

3-(a-D-Rhamnopyranosyl)-D-glucose is a glycosylation product that is synthesized by the methylation of glucose. It is a complex carbohydrate with a high purity, CAS number and custom synthesis. 3-(a-D-Rhamnopyranosyl)-D-glucose has been modified by fluorination and click chemistry to produce a versatile reagent for glycosylation reactions.

1,4:3,6-Dianhydro-2,5-di-O-methyl-D-Iditol is a sugar modified with methyl groups and fluorine. It can be used as a building block for oligosaccharides and polysaccharides. The compound is synthesized from commercially available starting materials. 1,4:3,6-Dianhydro-2,5-di-O-methyl-D-Iditol is soluble in water and methanol. This product has not been studied for toxicity or carcinogenicity in animals.

Tri-b-GalNAc-b-alanine-PEG3-biotin comprises a trivalent β-GalNAc ligand, a beta-alanine-PEG3 spacer, and a biotin tag in its structure. The ligand specifically targets ASGPRs (asialoglycoprotein receptors) on hepatocyte cells due to its multivalent GalNAc residues. The flexible linker (beta-alanine-PEG3) connects the GalNAc segment to biotin, allowing researchers to attach it to streptavidin-coated surfaces. Applications include lysosomal targeting, hepatocyte studies, and drug delivery.

H Type II-APD-BSA is a custom synthetic sugar that is used as an electron acceptor to reduce a variety of electron-deficient aromatic compounds. H Type II-APD-BSA can be modified with fluorine, which makes it an ideal reagent for the synthesis of complex carbohydrates. This product was created by methylation, click modification, and oligosaccharide synthesis. It has a CAS number, is made of saccharides and polysaccharides, and contains monosaccharides and sugars.

Lacto-N-fucopentaose II-BSA is a glycosylation agent that is derived from the natural substrate N-acetylgalactosamine. It is used in the synthesis of complex carbohydrates, such as glycoconjugates and polysaccharides. Lacto-N-fucopentaose II-BSA can be modified with methyl groups or fluorine atoms to generate derivatives, which are useful for studying glycosylation reactions. The CAS number for this product is 46645-96-8. This product is synthesized using custom methods and has been purified to high purity levels.

Disialylated pentaose type I (DSI-1) is a disaccharide sugar that is synthesized in high purity by custom synthesis. It is a complex carbohydrate that consists of five monosaccharides: glucose, galactose, mannose, fucose and N-acetylneuraminic acid. DSI-1 has been shown to have glycosylation and methylation activity. This product has been modified with fluorination and saccharide modification, as well as Click chemistry. Disialylated pentaose type I is used in the pharmaceutical industry as an intermediate for the production of glycoconjugates and in the food industry to produce artificial sweeteners.

L-altronojirimycin is a diterpene glycoside that belongs to the group of natural products that have inhibitory properties against lipid peroxidation. It has been shown to decrease the concentration of 1,2-dipalmitoylglycerophosphocholine (DPPC) in primary cells and reduce the rate of lipid peroxidation in a concentration-dependent manner. L-altronojirimycin inhibits the activity of enzymes such as acetylcholinesterase and phospholipase A2, which are involved in inflammation. This drug has also been shown to have cardioprotective effects and inhibit mutations in cardiac muscle cells. L-altronojirimycin has been tested for its long-term efficacy and shown to be effective against both bowel disease and cardiac effects.

Lacto-N-tetraose-BSA is a carbohydrate that contains four monosaccharides. It has been shown to be an autoantibody in patients with myasthenia gravis and can cause muscle weakness by binding to the muscle protein, actin. Lacto-N-tetraose-BSA has also been found to bind with nerve tissue and may be involved in the development of sclerosis. This carbohydrate is also negatively charged and agglutinates red blood cells. When used for immunofluorescence, it shows a strong reaction against glycoconjugates on the surface of neurons and nerve tissue. Lacto-N-tetraose-BSA binds specifically to bovine serum albumin (BSA) containing antibodies, which are produced by immune cells called B cells. The binding sites are located on the outer part of the molecule, near the sugar residues.

L-Idaric acid 1,4-lactone is a synthetic glycosylidic sugar that can be modified with fluorine compounds to create a variety of derivatives. It is used as a monomer in the synthesis of oligosaccharides, polysaccharides, and complex carbohydrates. L-Idaric acid 1,4-lactone can also be synthesized from methyl erythritol tetraacetate and glycerol in the presence of acetic anhydride.